These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 2007609)
1. Augmentation of murine lymphokine-activated killer cell cytotoxicity by beta-cyclodextrin-benzaldehyde. Kuroki Y; Ochiai H; Kurokawa M; Niwayama S; Kishimoto C; Tazawa K; Fujimaki M J Cancer Res Clin Oncol; 1991; 117(2):109-14. PubMed ID: 2007609 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of experimental and spontaneous pulmonary metastasis of murine RCT (+) sarcoma by beta-cyclodextrin-benzaldehyde. Masuyama K; Ochiai H; Niwayama S; Tazawa K; Fujimaki M Jpn J Cancer Res; 1987 Jul; 78(7):705-11. PubMed ID: 3114196 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of experimental pulmonary metastasis in mice by beta-cyclodextrin-benzaldehyde. Ochiai H; Niwayama S; Masuyama K J Cancer Res Clin Oncol; 1986; 112(3):216-20. PubMed ID: 3782260 [TBL] [Abstract][Full Text] [Related]
4. [Inhibition of pulmonary metastases in mice by beta-cyclodextrin-benzaldehyde]. Masuyama K; Ochiai H; Ishizawa S; Yamashita I; Matsui H; Tazawa K; Niwayama S; Fujimaki M Gan To Kagaku Ryoho; 1988 Mar; 15(3):443-7. PubMed ID: 3348630 [TBL] [Abstract][Full Text] [Related]
5. Adoptive immunotherapy using lymphokine-activated killer cells and recombinant interleukin-2 in preventing and treating spontaneous pulmonary metastases of syngeneic Dunning rat prostate tumor. Tjota A; Zhang YQ; Piedmonte MR; Lee CL J Urol; 1991 Jul; 146(1):177-83. PubMed ID: 2056587 [TBL] [Abstract][Full Text] [Related]
6. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors. Mulé JJ; Krosnick JA; Rosenberg SA J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of murine lymphokine-activated killer cell induction by a factor produced by Nocardia rubra cell wall skeleton-stimulated T cells. Kawase I; Shirasaka T; Ikeda T; Hara H; Tanio Y; Watanabe M; Saito S; Masuno T; Kishimoto S; Yamamura Y Jpn J Cancer Res; 1989 Nov; 80(11):1098-105. PubMed ID: 2481664 [TBL] [Abstract][Full Text] [Related]
8. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491 [TBL] [Abstract][Full Text] [Related]
9. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells. Saarloos MN; Khoo NK; Lala PK Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293 [TBL] [Abstract][Full Text] [Related]
10. Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity. Tunru IS; Suzuki H; Yano S Int J Cancer; 1991 Jun; 48(4):568-73. PubMed ID: 2045201 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of murine lymphokine-activated killer cell activity by retinoic acid. Lin TH; Chu TM Cancer Res; 1990 May; 50(10):3013-8. PubMed ID: 1970751 [TBL] [Abstract][Full Text] [Related]
12. Effect of granulocyte-macrophage colony-stimulating factor on lymphokine-activated killer cell induction. Stewart-Akers AM; Cairns JS; Tweardy DJ; McCarthy SA Blood; 1993 May; 81(10):2671-8. PubMed ID: 8490177 [TBL] [Abstract][Full Text] [Related]
14. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types. Papa MZ; Mulé JJ; Rosenberg SA Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517 [TBL] [Abstract][Full Text] [Related]
15. Gelatin sponge model of effector recruitment: tumoricidal activity of adherent and non-adherent lymphokine-activated killer cells after culture in interleukin-2. Akporiaye ET; Barbieri CA; Stewart CC; Bender JG J Leukoc Biol; 1991 Feb; 49(2):189-96. PubMed ID: 1991999 [TBL] [Abstract][Full Text] [Related]
16. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes. Flexman JP; Manning LS; Robinson BW Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789 [TBL] [Abstract][Full Text] [Related]
17. Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro. Helfand SC; Soergel SA; Modiano JF; Hank JA; Sondel PM Cancer Biother; 1994; 9(3):237-44. PubMed ID: 7820185 [TBL] [Abstract][Full Text] [Related]
18. Induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2. Suzuki M; Higuchi S; Taki Y; Taki S; Miwa K; Hamuro J Int J Immunopharmacol; 1990; 12(6):613-23. PubMed ID: 2272726 [TBL] [Abstract][Full Text] [Related]
19. Human lymphokine-activated killer cells augment immunotherapy of human colon carcinoma xenografts with monoclonal antibody D612. Pendurthi TK; Schlom J; Primus FJ J Immunother (1991); 1991 Feb; 10(1):2-12. PubMed ID: 2012797 [TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of lymphokine-activated killer cells loaded with 4'-deoxy-4'-iododoxorubicin: therapeutic effect in mice bearing lung metastases. Mandruzzato S; Rosato A; Bronte V; Zanovello P; Amboldi N; Ballinari D; Collavo D Cancer Res; 1994 Feb; 54(4):1016-20. PubMed ID: 8313356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]